Evidence map›Paper›PMID 28628107›Full record

ArticleNature genetics2017

Identification of sequence variants influencing immunoglobulin levels.

Stefan Jonsson, Gardar Sveinbjornsson, Aitzkoa Lopez de Lapuente Portilla, Bhairavi Swaminathan, Rosina Plomp, Gillian Dekkers, Ram Ajore, Mina Ali, Arthur E H Bentlage, Evelina Elmér and 28 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Stefan JonssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-5401-8589
Gardar SveinbjornssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Aitzkoa Lopez de Lapuente PortillaHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Bhairavi SwaminathanHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Rosina PlompCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
Gillian DekkersExperimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-9127-356X
Ram AjoreHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Mina AliHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Arthur E H BentlageExperimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Evelina ElmérHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Gudmundur I EyjolfssonLaboratory in Mjodd, Reykjavik, Iceland.
Sigurjon A GudjonssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Urban GullbergHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Arnaldur GylfasondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Bjarni V HalldorssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-0756-0767
Markus HanssonHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.ORCID http://orcid.org/0000-0002-7715-4548
Hilma HolmdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Åsa JohanssonHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Ellinor JohnssonHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Aslaug JonasdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Bjorn R LudvikssonDepartment of Immunology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Asmundur OddssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
Isleifur OlafssonDepartment of Clinical Biochemistry, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Sigurgeir OlafssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-1711-2757
Olof SigurdardottirDepartment of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
Asgeir SigurdssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Lilja StefansdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Gisli MassondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Patrick SulemdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7123-6123
Manfred WuhrerCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-0814-4995
Anna-Karin WihlborgHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Gudmar ThorleifssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Daniel F GudbjartssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Unnur ThorsteinsdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Gestur VidarssonExperimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0001-5621-003X
Ingileif JonsdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-8339-150X
Björn NilssonHematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden.
Kari StefanssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulins are the effector molecules of the adaptive humoral immune system. In a genome-wide association study of 19,219 individuals, we found 38 new variants and replicated 5 known variants associating with IgA, IgG or IgM levels or with composite immunoglobulin traits, accounted for by 32 loci. Variants at these loci also affect the risk of autoimmune diseases and blood malignancies and influence blood cell development. Notable associations include a rare variant at RUNX3 decreasing IgA levels by shifting isoform proportions (rs188468174[C>T]: P = 8.3 × 10

Indexed as

Genetic VariationCohort StudiesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHematopoiesisHumansIcelandImmunity, HumoralImmunoglobulin Class SwitchingImmunoglobulin IsotypesImmunoglobulinsMalePolymorphism, Single NucleotideSwedenImmunoglobulin IsotypesImmunoglobulins

Identifiers

PMID28628107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.